Literature DB >> 33547140

Unexpected bradycardia after a first dose of doxazosin.

James Edward Pigot1, Matthew Chak Hin Szeto2.   

Abstract

Entities:  

Keywords:  adverse events; clinical pharmacology; education & training (see medical education & training); hypertension; internal medicine

Mesh:

Substances:

Year:  2021        PMID: 33547140      PMCID: PMC9234413          DOI: 10.1136/postgradmedj-2020-138434

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   4.973


× No keyword cloud information.
An 89-year-old man with a medical history of hypertension, prostate cancer and postural hypotension presented to the emergency department with worsening headache and fatigue. His general practitioner had recently stopped his daily 10 mg of amlodipine due to symptoms of postural hypotension. On initial assessment, his heart rate was 67 beats per minute, blood pressure 219/104 mm Hg, respiratory rate 16 breaths per minute and oxygen saturations 98% on room air. He did not have any chest pain, signs of heart failure, acute kidney injury or new confusion. An ECG showed first-degree atrioventricular block. The patient was given 4 mg of modified-release doxazosin for his hypertension. There was no documentation in the emergency department notes about why this had been chosen as the first-line intervention. Two hours later, he complained to nursing staff that he was about to pass out. Repeat observations showed a blood pressure of 60/30 mm Hg and a heart rate of 46 beats per minute. A second ECG showed a narrow complex escape rhythm (figure 1).
Figure 1

ECG showing narrow complex escape rhythm.

ECG showing narrow complex escape rhythm. He received 1.5 L of 0.9% sodium chloride solution and 800 μg of atropine to good effect symptomatically. His heart rate and blood pressure improved to 80 beats per minute and 160/90 mm Hg, respectively. Due to receiving modified-release doxazosin, which has a peak concentration level in the blood 8 hours after being taken as opposed to 2 hours for standard-release doxazosin, he was admitted for observation overnight. Overnight, he received a further 500 μg of atropine with 500 mL of 0.9% sodium chloride solution after dropping his blood pressure to 65/40 mm Hg with a heart rate of 48 beats per minute. He was discharged home the following day once he was asymptomatic (figure 2).
Figure 2

ECG taken once the patient was asymptomatic the following morning.

ECG taken once the patient was asymptomatic the following morning. The medication doxazosin belongs to the class of medications known as alpha-adrenergic blockers. This group of medications lowers blood pressure by causing vasodilatation of vascular smooth muscle. This is usually accompanied by a reflex tachycardia as the heart compensates to maintain cardiac output. Alpha-blockers are well documented to exhibit the first-dose phenomenon, whereby there is a sudden and severe fall in blood pressure, especially during postural change.1 It is for this reason that alpha-blockers are contraindicated in patients with known postural hypotension. Although X’s marked hypotension could be explained, his accompanying bradycardia was unusual. A literature review showed that alpha-blockers are more commonly associated with a reflex tachycardia in response to hypotension, and it is very unusual for an accompanying bradycardia.2 3 One possible explanation for the above finding in this patient could be attributed to the Bezold-Jarisch reflex.4 During periods of significant hypotension, this can lead to the ventricles being drastically under filled. This in turn can lead to stimulation of the cardiac vagal afferent fibres of the parasympathetic nervous system and inhibition of the sympathetic nervous system, resulting in further vasodilatation, hypotension and a paradoxical bradycardia, instead of a compensatory tachycardia, which further compounds the symptoms.4 This response could be further exaggerated in patients with autonomic failure as manifested through postural hypotension.5 The key learning points from this episode were: Recognise the first-dose phenomenon of alpha-blockers and in the need for caution when prescribing for elderly patients. Apply National Institute for Health and Care Excellence (NICE) guidance to measure standing as well as seated blood pressure in patients over 80 years old. If postural hypotension is detected, to treat based on standing blood pressure. Ensuring that an adequate period of observation is conducted in those who experience an adverse drug reaction due to modified-release tablets. Explain the Bezold-Jarisch reflex and its potentially life-threatening implication.
  5 in total

Review 1.  Clinical relevance of the Bezold-Jarisch reflex.

Authors:  Jason A Campagna; Christopher Carter
Journal:  Anesthesiology       Date:  2003-05       Impact factor: 7.892

2.  Differential effects of urapidil and doxazosin on heart rate.

Authors:  Kurt Stoschitzky; Gergana Stoschitzky; Manfred Wonisch; Helmut Brussee
Journal:  Eur J Clin Pharmacol       Date:  2007-01-16       Impact factor: 2.953

Review 3.  Pathophysiological basis of orthostatic hypotension in autonomic failure.

Authors:  A A Smit; J R Halliwill; P A Low; W Wieling
Journal:  J Physiol       Date:  1999-08-15       Impact factor: 5.182

4.  Immediate cardiovascular responses to oral prazosin--effects of concurrent beta-blockers.

Authors:  H L Elliott; K McLean; D J Sumner; P A Meredith; J L Reid
Journal:  Clin Pharmacol Ther       Date:  1981-03       Impact factor: 6.875

5.  A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.

Authors:  M H Frick; P Halttunen; P Himanen; M Huttunen; P Pörsti; T Pitkäjärvi; L Pöyhönen; M L Pyykönen; P Reinikainen; P Salmela
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.